| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| rilonacept | interleukin-1 alpha | biotech | NA | drugbank , DGIDB | Gout[MeSHID:D006073] Voting[MeSHID:D011057] Cryopyrin-Associated Periodic Syndromes[MeSHID:D056587] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Arthritis[MeSHID:D001168] |
21.22 | approved,investigational | binder |
| rilonacept | interleukin-1 beta | biotech | Successful target | TTD , drugbank , DGIDB | Gout[MeSHID:D006073] Voting[MeSHID:D011057] Cryopyrin-Associated Periodic Syndromes[MeSHID:D056587] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Arthritis[MeSHID:D001168] |
3.44 | approved,investigational | binder |
| rilonacept | interleukin-1 beta | biotech | Successful target | TTD , drugbank , DGIDB | Gout[MeSHID:D006073] Voting[MeSHID:D011057] Cryopyrin-Associated Periodic Syndromes[MeSHID:D056587] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Arthritis[MeSHID:D001168] |
3.44 | approved,investigational | binder,inhibitor |
| rilonacept | interleukin-1 receptor antagonist protein | biotech | NA | drugbank | Gout[MeSHID:D006073] Voting[MeSHID:D011057] Cryopyrin-Associated Periodic Syndromes[MeSHID:D056587] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Arthritis[MeSHID:D001168] |
NA | approved,investigational | binder |
| click here to return to the previous page | ||||||||